The North America molecular diagnostics market is expected to grow from US$ 8,056.48 million in 2022 to US$ 20,740.38 million by 2030. It is estimated to grow at a CAGR of 12.5% from 2022 to 2030.
Expansion of Point-of-Care Testing and Innovative Product Development Propel Growth in North America’s Molecular Diagnostics Market
Point-of-care testing (POCT) is transforming healthcare by delivering rapid, on-site diagnostic solutions across a spectrum of clinical needs—from glucose monitoring to coagulation analysis. By bypassing sample transportation and processing delays, POCT empowers clinicians to accelerate treatment decisions and streamline patient care. This technology is gaining rapid traction among healthcare providers and patients alike, driven by its versatility in diagnostics, therapeutics, and monitoring. A significant catalyst for adoption has been the demand for home-based care, particularly during the COVID-19 pandemic, where POCT minimized exposure risks by enabling remote testing. As the preference for decentralized healthcare grows, POCT continues to bolster the molecular diagnostics sector.
Segmentation of the North America Molecular Diagnostics Market
The market is categorized based on disease area, technology, products and services, end users, and country.
- By Disease Area:
- Infectious Diseases (largest market share in 2022)
- Oncology
- Genetic Testing
- Cardiac Diseases
- Immune System Disorders
- Others
- By Technology:
- Polymerase Chain Reaction (PCR) (largest market share in 2022)
- Subsegments: RT-PCR, qPCR, Multiplex PCR, and Others
- In Situ Hybridization
- Isothermal Nucleic Acid Amplification Technology (INAAT)
- DNA Sequencing and Next-Generation Sequencing (NGS)
- DNA Microarrays
- Others
- Polymerase Chain Reaction (PCR) (largest market share in 2022)
- By Products and Services:
- Assays and Kits (largest market share in 2022)
- Instruments
- Services and Software
- By End Users:
- Diagnostic Laboratories (largest market share in 2022)
- Hospitals and Clinics
- Research and Academic Institutes
- Others
- By Country:
- United States (dominant market in 2022)
- Canada
- Mexico
Key Players in the North America Molecular Diagnostics Market
Several leading companies drive the growth and innovation in the North American molecular diagnostics market, including:
- Abbott Laboratories
- Agilent Technologies Inc.
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd.
- Qiagen NV
- bioMérieux SA
- Illumina Inc.
- Danaher
- Siemens Healthineers AG
- Novartis AG
- TBG Diagnostics Limited
The ongoing advancements in molecular diagnostics, coupled with increasing demand for point-of-care solutions, position North America as a key player in this evolving market.
North America Molecular Diagnostics Market Overview
The North American market, segmented into the U.S., Canada, and Mexico, is fueled by advanced technology adoption, robust R&D investments, a strong healthcare industry presence, and expanding applications of molecular diagnostics. In 2022, the U.S. accounted for the largest market share, attributed to its cutting-edge healthcare infrastructure and high uptake of innovative diagnostic solutions.
Market Segmentation and Key Trends
The market is analyzed across the following segments:
- Disease Area:
- Infectious diseases dominated the market in 2022, driven by heightened demand for rapid pathogen detection.
- Other segments include oncology, genetic testing, cardiac diseases, immune disorders, and niche applications.
- Technology:
- Polymerase Chain Reaction (PCR) led the sector, with subcategories such as RT-PCR, qPCR, and multiplex PCR.
- Additional technologies include in situ hybridization, isothermal amplification (INAAT), DNA sequencing/NGS, microarrays, and emerging methods.
- Product and Services:
- Assays and kits claimed the largest share, reflecting widespread use in diagnostic workflows.
- Instruments and software/services also contribute to market dynamics.
- End Users:
- Diagnostic laboratories held the highest share, underscoring their central role in testing.
- Hospitals/clinics, research institutes, and other settings further drive demand.
Future Outlook
With projections extending to 2030, the North America molecular diagnostics market is poised for sustained growth, driven by technological breakthroughs, escalating demand for personalized medicine, and the expanding role of POCT in modern healthcare delivery.
Other Reports:
North America Multiple Sclerosis Therapeutics Market: https://www.quora.com/profile/Business-Market-Insights-1/North-America-Multiple-Sclerosis-Therapeutics-Market-2027-Size-Share-Industry-Trends-Business-Revenue-Forecast-and-S
North America Artificial Intelligence in Market: https://penzu.com/p/6a525833f613cd65
North America Long Read Sequencing Market: https://postyourarticle.com/north-america-long-read-sequencing-market-analysis-trends-share-development-policies-and-future-growth-2028/
North America Stevia Market: https://sites.google.com/view/north-america-long-read-sequen/home
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
